OS Therapies Inc
About OS Therapies Inc
OS Therapies Incorporated is a clinical-stage biopharmaceutical company focused on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors, with an emphasis on cancers of the bone in children and young adults. The company is the successor to an LLC and was incorporated as a Delaware corporation on June 24, 2019, based in Rockville, Maryland. It operates in the biotechnology sector with an estimated revenue range of $1M-$10M and 11-50 employees.
- 🔗 OS Therapies Company Overview, Contact Details & Competitors | LeadIQ
- 🔗 OS Therapies - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 OS Therapies - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 OS Therapies closes additional private placement round
- 🔗 SEC Filing 10-K filing
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Company completed a private placement of $7.17M with Series A Preferred Stock convertible to common stock.
- Focuses on osteosarcoma treatments for pediatric and young adult patients with high unmet need.
- Headquartered in Grasonville, MD with operations as a clinical-stage biopharma entity.
- Has completed multiple funding rounds totaling between $8M and $37M according to third-party trackers.
Ask StreetZero about OS Therapies Inc
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account